| 000 | 01703 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513205957.0 | ||
| 264 | 0 | _c20000811 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(00)00004-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReuben, M | |
| 245 | 0 | 0 |
_aNicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMar 2000 |
||
| 300 |
_a39-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMecamylamine _xpharmacology |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNicotine _xpharmacology |
| 650 | 0 | 4 |
_aNicotinic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aNicotinic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Nicotinic _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aSynaptosomes _xdrug effects |
| 650 | 0 | 4 |
_aTetrodotoxin _xpharmacology |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aBoye, S | |
| 700 | 1 | _aClarke, P B | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 393 _gno. 1-3 _gp. 39-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(00)00004-2 _zAvailable from publisher's website |
| 999 |
_c10724131 _d10724131 |
||